Nonalcoholic fatty liver disease. Nonalcoholic fatty liver disease (NAFLD)
Conditions
Interventions
Intervention 1: Intervention 1 : the intervention group In addition to teaching life style and training package similar at baseline and follow up with phone calls weekly, daily intake of 40 mg pickle
Treatment - Drugs
Lifestyle
Intervention 1 : the intervention group In addition to teaching life style and training package similar at baseline and follow up with phone calls weekly, daily intake of 40 mg pickled capers fruit w
Intervention 2: teaching life style and training package similar at baseline and follow up with phone calls weekly in the control group
Sponsors
Vice chancellor for research, Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
12 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: nonalcoholic fatty liver (elevated SGPTand sonography results); age 12 to 80 years. Exclusion criteria: Hyperlipidemia during treatment or Severe hyperlipidemia; pregnancy and lactation; Coagulopathies; thyroid disease; cirrhosis, viral hepatitis; Overt diabetes; Drugs that affect metabolism or liver enzyme levels such as OCP, Corticosteroid, ..; patients who are hospitalized in the course of treatment and therefore could not continue the treatment; patients who cannot eat pickled capers fruit for various reasons; Patients who cannot adhere to the guidelines recommended in the lifestyle training.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SGPT. Timepoint: Before the intervention, the end of the twelfth week intervention. Method of measurement: Blood sample.;SGOT. Timepoint: Before the intervention, the end of the twelfth week intervention. Method of measurement: Blood sample. | — |
Secondary
| Measure | Time frame |
|---|---|
| Total chlo. Timepoint: Before the intervention, the end of the twelfth week intervention. Method of measurement: Blood sample.;FBS. Timepoint: Before the intervention, the end of the twelfth week intervention. Method of measurement: Blood sample.;TG. Timepoint: Before the intervention, the end of the twelfth week intervention. Method of measurement: Blood sample.;VLDL. Timepoint: Before the intervention, the end of the twelfth week intervention. Method of measurement: Blood sample.;LDL. Timepoint: Before the intervention, the end of the twelfth week intervention. Method of measurement: Blood sample.;HDL. Timepoint: Before the intervention, the end of the twelfth week intervention. Method of measurement: Blood sample.;Fasting Insulin. Timepoint: Before the intervention, the end of the twelfth week intervention. Method of measurement: Blood sample.;Cs-CRP. Timepoint: Before the intervention, the end of the twelfth week intervention. Method of measurement: Blood sample.;BMI. Timepoint: Before the intervention, the end of the twelfth week intervention. Method of measurement: Digital weighing scales and measuring the height of meters.;Appetite. Timepoint: Before the intervention, the end of the twelfth week intervention. Method of measurement: VAS Questionnaire.;Insulin resistance. Timepoint: Before the intervention, the end of the twelfth week intervention. Method of measurement: HOMA Index. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNarjes.Khavasi
Tabriz University of Medical and Sciences
Outcome results
None listed